Table 3.
Imaging agent | Hepatic transporters | Species | Application | Ref | |
---|---|---|---|---|---|
SPECT | |||||
[99mTc]Mebrofenin | OATP1B1/3, MRP2, MRP3 | Mice, rats, humans | Mechanistic assessment of hepatic clearance; assessment of the effect of genetic polymorphisms or disease on hepatic transporter activity | [106–112] | |
[99mTc]PMT | OATP1B1/3, P-gp, MRP2 | Rats, rabbits, humans | Probe validation | [116] | |
[111In]EOB-DTPA | OATPs | Mice | Probe validation | [117] | |
[99mTc]DTPA-CDCA | OATP1B1/3, MRP2 | Mice | Probe validation | [121] | |
[99mTc]DTPA-CA | OATP1B1/3, MRP2 | Mice | Probe validation | [121] | |
[131I]NP-59 | OATP1B1/3, BCRP | Mice | Probe validation | [120] | |
MRI | |||||
Gadoxetate | OATPs, MRP2 | Mice, rats, humans | Mechanistic assessment of hepatic clearance; assessment of the effect of genetic polymorphisms or disease on hepatic transporter activity | [101,102,124–132] | |
BOPTA | OATPs, MRP2 | Perfused rat livers | Mechanistic assessment of hepatic clearance | [133–137] |